What is the NGEN.V share price today?

This page shows the latest available NervGen Pharma Corp. (NGEN.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is NervGen Pharma Corp. listed?

NervGen Pharma Corp. trades on the TSX Venture Exchange under the symbol NGEN.V, ISIN CA64082X2032.

How large is NervGen Pharma Corp.?

Its market capitalisation is approximately 407.94M CAD, based on the latest available price and share count from our data provider.

TSX Venture Exchange (TSXV) · NGEN.V · ISIN CA64082X2032

NervGen Pharma Corp.

No trading activity has been reported for this listing since March 16, 2026. It may be delisted, halted or inactive.

5.15 CAD

March 16, 2026

NervGen Pharma Corp. (NGEN.V) trades on the TSX Venture Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 407.94M CAD. The company reports around 11 employees. Its ISIN is CA64082X2032. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Key facts

Exchange

TSX Venture Exchange (TSXV)

ISIN

CA64082X2032

Sector

Healthcare

Industry

Biotechnology

Country

Market cap

407.94M CAD

Employees

Previous close

5.00 CAD

Day range

4.93 – 5.23

52-week range

2.57 – 8.49

Volume

66.94K

50-day average

6.19 CAD

200-day average

4.60 CAD

Asset type

Equity

About NervGen Pharma Corp.

NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.

Company website

Frequently asked

What is the NGEN.V share price today?: This page shows the latest available NervGen Pharma Corp. (NGEN.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is NervGen Pharma Corp. listed?: NervGen Pharma Corp. trades on the TSX Venture Exchange under the symbol NGEN.V, ISIN CA64082X2032.
How large is NervGen Pharma Corp.?: Its market capitalisation is approximately 407.94M CAD, based on the latest available price and share count from our data provider.

All NervGen Pharma Corp. data comes from exchange and provider feeds for the TSX Venture Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.